These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6083957)

  • 21. Substitution of antithrombin III in shock and DIC: a randomized study.
    Blauhut B; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical value of antithrombin III].
    Vinazzer H; Bergmann H; Blauhut B
    Wien Med Wochenschr; 1984 Jun; 134(12):279-83. PubMed ID: 6380122
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antithrombin III substitution for optimization of the heparin effect during extracorporeal circulation in heart surgery].
    Dietrich W; Schroll A; Göb E; Barankay A; Richter JA
    Anaesthesist; 1984 Sep; 33(9):422-7. PubMed ID: 6496919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M
    Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antithrombin III in various conditions in internal medicine].
    Malý J; Pecka M; Pidrman V; Zadák Z; Gregor J; Jebavý L; Bláha M; Siroký O
    Vnitr Lek; 1997 Oct; 43(10):645-8. PubMed ID: 9601877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
    Prager RL; Dunn EL; Kirsh MM; Penner JA
    Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
    Peyrin JC; Waldmann V; Girardet P; Pouzol P; Duret J; Fargnoli JM; Magne JL; Perron Y
    J Chir (Paris); 1986; 123(6-7):417-23. PubMed ID: 3771670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of prophylactic heparinization on DIC arising from transitory circulatory arrest in dogs.
    Takemoto Y; Tanabe J; Tanaka S; Fukuda A; Fujii C; Kohama A; Shibata S
    Circ Shock; 1985; 15(2):131-9. PubMed ID: 3978765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of components of the coagulation systems in normal individuals and septic shock patients.
    Smith-Erichsen N; Aasen AO; Gallimore MJ; Amundsen E
    Circ Shock; 1982; 9(5):491-7. PubMed ID: 7172424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.